| Literature DB >> 32747793 |
Ramon I Klein Geltink1,2, Joy Edwards-Hicks1, Petya Apostolova1, David O'Sullivan1, David E Sanin1, Annette E Patterson1, Daniel J Puleston1, Nina A M Ligthart1, Joerg M Buescher1, Katarzyna M Grzes1, Agnieszka M Kabat1, Michal Stanczak1, Jonathan D Curtis1, Fabian Hässler1, Franziska M Uhl3,4, Mario Fabri1,5, Robert Zeiser3, Edward J Pearce1,4, Erika L Pearce6.
Abstract
CD8+ effector T (TE) cell proliferation and cytokine production depends on enhanced glucose metabolism. However, circulating T cells continuously adapt to glucose fluctuations caused by diet and inter-organ metabolite exchange. Here we show that transient glucose restriction (TGR) in activated CD8+ TE cells metabolically primes effector functions and enhances tumour clearance in mice. Tumour-specific TGR CD8+ TE cells co-cultured with tumour spheroids in replete conditions display enhanced effector molecule expression, and adoptive transfer of these cells in a murine lymphoma model leads to greater numbers of immunologically functional circulating donor cells and complete tumour clearance. Mechanistically, TE cells treated with TGR undergo metabolic remodelling that, after glucose re-exposure, supports enhanced glucose uptake, increased carbon allocation to the pentose phosphate pathway (PPP) and a cellular redox shift towards a more reduced state-all indicators of a more anabolic programme to support their enhanced functionality. Thus, metabolic conditioning could be used to promote efficiency of T-cell products for adoptive cellular therapy.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32747793 DOI: 10.1038/s42255-020-0256-z
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812